- Gene Therapy Pioneer Jerry R. Mendell, M.D., Named to Inaugural TIME100 Health List of the 100 Most Influential People in Global Health
- Sarepta Therapeutics Announces First Quarter 2024 Financial Results and Recent Corporate Developments
- Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Sarepta Therapeutics to Announce First Quarter 2024 Financial Results
- Sarepta Therapeutics to Present at Upcoming Investor Conferences
- Sarepta Therapeutics Announces Call for Applications for the 7th Annual Route 79, The Duchenne Scholarship Program
- Sarepta Therapeutics Announces Fourth Quarter and Full-Year 2023 Financial Results and Recent Corporate Developments
More ▼
Key statistics
On Thursday, Sarepta Therapeutics Inc (AB3A:STU) closed at 117.20, -15.50% below its 52-week high of 138.70, set on May 23, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 118.05 |
---|---|
High | 118.05 |
Low | 116.20 |
Bid | 117.35 |
Offer | 117.85 |
Previous close | 119.40 |
Average volume | 2.67 |
---|---|
Shares outstanding | 94.52m |
Free float | 89.83m |
P/E (TTM) | 1,610.39 |
Market cap | 12.13bn USD |
EPS (TTM) | 0.0797 USD |
Data delayed at least 15 minutes, as of May 23 2024.
More ▼